SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-013627
Filing Date
2018-09-24
Accepted
2018-09-24 10:00:15
Documents
4
Period of Report
2018-09-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 24210
2 ex3-1.htm EX-3.1 1150
3 image_001.jpg GRAPHIC 27991
4 ex3-1_001.jpg GRAPHIC 301731
  Complete submission text file 0001493152-18-013627.txt   480774
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55453 | Film No.: 181082793
SIC: 2834 Pharmaceutical Preparations